Alesta Therapeutics
PrivateLast Round
Series A
Jan 8, 2025
Total Funding Raised
$67M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Alesta Therapeutics operates in Healthcare & Life Sciences and is based in Leiden. Its latest recorded funding round was a Series A round in January 2025.
Alesta Therapeutics is a biotechnology company developing novel oral small molecule therapies for underserved rare diseases such as hypophosphatasia (HPP) and Charcot-Marie-Tooth (CMT).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alesta Therapeutics Comparables
Compare Alesta Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Augustine Therapeutics | 78% | |
| ReviR Therapeutics | 72% | |
| BioMarin Pharmaceutical Inc. | 71% |
For institutional investors. Book with your work email.
Alesta Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Alesta Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Droia Ventures | Series A |
| Thuja Capital | Series A |
| Frazier Life Sciences | Series A |
| RV Invest | Series A |
| RTW Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 76% MoM.
- Jul 28, 2026
Monthly visitors grew 282% MoM, from 263 to 1K.
For institutional investors. Book with your work email.
Alesta Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Alesta Therapeutics's valuation, stock price, and market status.
Is Alesta Therapeutics a public or private company?
Alesta Therapeutics is a private company.
What is the current stock price of Alesta Therapeutics?
Alesta Therapeutics is a private company, so its shares have no public market price. Caplight tracks Alesta Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Alesta Therapeutics worth (valuation)?
Valuation information for Alesta Therapeutics is not publicly available.
Can I buy Alesta Therapeutics stock?
Alesta Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Alesta Therapeutics's last funding round?
Alesta Therapeutics's most recent funding round was Series A on January 8, 2025.
Who are the main investors in Alesta Therapeutics?
Key investors in Alesta Therapeutics include Droia Ventures, Frazier Life Sciences.
Will Alesta Therapeutics IPO soon?
No public IPO plans have been announced for Alesta Therapeutics.
How can I track Alesta Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Alesta Therapeutics's shares on secondary markets.